Epidemiologic and animal studies have provided evidence that hormone replacement therapy can reduce the risk of stroke. Doppler ultrasound measurements of blood flow show a positive effect of estrogens on the cardiovascular system, which is only slightly modified by progestins. Ultrasound measurements of intima-media thickness showed a positive influence of long-term hormone replacement therapy on the cerebral vasculature. The intima-media thickness, a marker of complex atherosclerosis decreases with hormone replacement therapy. The number of atherosclerotic plaques in extracranial cerebral vessels is significantly lower in patients receiving hormone replacement than in controls. One study suggested that estrogen replacement can lead to regression of atherosclerotic plaques. Hormone replacement therapy may reduce the risk for developing and progression of cerebrovascular atherosclerosis. In patients with a history of stroke the possible benefits of hormone replacement have to be weighed against risks, particularly in patients with other risk factors. We review our results and the literature.
Read full abstract